
Sign up to save your podcasts
Or


Welcome back! Today we are featuring the two FDA-approved medications for tardive dyskinesia, the VMAT2 inhibitors Valbenazine (Ingrezza) and Deutetrabenazine (Austedo).
References:
https://pubmed.ncbi.nlm.nih.gov/41626799/
https://www.ncbi.nlm.nih.gov/books/NBK548187/
https://pubmed.ncbi.nlm.nih.gov/41626799/
By Dr. Tanner Hewitt, Dr. Larry Wang and Dr. Bradley Miller4.8
147147 ratings
Welcome back! Today we are featuring the two FDA-approved medications for tardive dyskinesia, the VMAT2 inhibitors Valbenazine (Ingrezza) and Deutetrabenazine (Austedo).
References:
https://pubmed.ncbi.nlm.nih.gov/41626799/
https://www.ncbi.nlm.nih.gov/books/NBK548187/
https://pubmed.ncbi.nlm.nih.gov/41626799/

1,331 Listeners

141 Listeners

3,374 Listeners

158 Listeners

1,363 Listeners

732 Listeners

296 Listeners

209 Listeners

566 Listeners

489 Listeners

756 Listeners

260 Listeners

200 Listeners

5 Listeners

20 Listeners